Health TrialsbyHealthPanel

A Study of Ward Admissions for Haematuria

ConditionsUrologic DiseasesHematuriaHematuria; BenignBladder CancerRenal CancerUrothelial Carcinoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorBritish Urology Researchers in Surgical Training

About this trial

This multicenter, prospective observational study will evaluate national and international practice variations (if present) in the emergency management of patients admitted to hospital with haematuria, inform a consensus guideline for best practice and provide evidence to design an implementation study to optimise haematuria management pathway.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients are included if they are over 16 years of age or older and admitted to a participating urological secondary care centre

admitted as an emergency with haematuria as the primary or secondary diagnosis under the primary or joint care of urology

Disqualifiers

any patients under 16 years of age

patients with catheter-related urethral trauma (defined as haemturia immediately after insertion of a urethral catheter that was documented as traumatic by the clinician, with no previous history of haemturia prior to catheter insertion)

patients that are in hospital less than 24 hours.

Trial population

Patients will be included consecutively if they are over 18 years of age and admitted to a participating secondary care centre as an emergency with haematuria under the primary or joint care of the urology team.

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

  • Inpatient work-up and management

    Other intervention

    The study hypothesis is that there is significant international and national variation in the diagnostic workup and management of patients requiring admission to the hospital with haematuria. Increased length of stay and poor outcomes in terms of mortality and healthcare costs are associated with management practices. The CRF will collect datapoints on inpatient work-up and management.

Treatment groups

1,050 Participants
are divided into 1 treatment group
Group A: Prospective, obersational cohort (single cohort study)1 intervention

Trial outcomes

Primary outcomes

1

Length of inpatient stay

Number of calendar days between the day of admission in the index hospital admission episode and the day of discharge from the hospital.

Time frame
At 90 days

Secondary outcomes

1

Mortality rate

Time frame
At 90 days
2

Readmission rate

Time frame
At 90 days
3

Time to definitive diagnosis

Defined as the number of days between original presentation and final diagnosis.

Time frame
At 90 days
4

Number of days alive and out of hospital

Composite endpoint - cumulative days alive and out of hospital

Time frame
At 90 days.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

British Urology Researchers in Surgical Training

Lead sponsor

Source ClinicalTrials.gov
Apply now